Genetic medicines such as cell and gene therapies and mRNA vaccines offer extraordinary promise for treating a variety of diseases, including genetic disorders, cancer, and autoimmune diseases. These ...

(MENAFN- EIN Presswire) EINPresswire/ -- The Global Gene Synthesis Market size is estimated to be valued at USD 2.8 billion in 2025 and is expected to reach USD 6.1 billion by 2032, exhibiting a ...

DNA Script announced a significant advancement in oligonucleotide synthesis technology, enabling the production of custom DNA sequences of up to 500 nucleotides in length with unprecedented sequence ...

Austin, United States, Nov. 21, 2024 (GLOBE NEWSWIRE) -- “According to SNS Insider, The DNA Synthesizer Market valued at USD 270.40 million in 2023 and is projected to reach USD 922.11 million by 2032 ...

The following article is an opinion piece written by Dan Lin-Arlow. The views and opinions expressed in this article are those of the author and do not necessarily reflect the official position of ...

Synplogen, a synthetic biology startup spun out of Kobe University's Graduate School of Science, Technology and Innovation that provides custom DNA synthesis and Gene Therapy Biofoundry™ services, has ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

The global DNA Origami market is poised for significant growth, with an expected value of USD 105.2 million by 2033, up from USD 41.3 million in 2023, reflecting a robust CAGR of 9.8% from 2024 to ...